Baxter dismisses lawsuit as "without merit"
This article was originally published in Clinica
Baxter International has dismissed as "completely without merit" a class action lawsuit alleging the company issued materially false and misleading press releases relating to the performance of its bioscience and renal divisions. "This appears to be an off-the-shelf suit, typically filed anytime a company's stock price declines," said a spokesperson. The company plans to vigorously contest the suit, she added.